# Evaluation of BTX Injections in Treatment of Bruxism

> **NCT05980559** · PHASE3 · UNKNOWN · sponsor: **Alexandria University** · enrollment: 12 (estimated)

## Conditions studied

- Bruxism

## Interventions

- **DRUG:** Xeomin

## Key facts

- **NCT ID:** NCT05980559
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-15
- **Primary completion:** 2024-01-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05980559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05980559, "Evaluation of BTX Injections in Treatment of Bruxism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05980559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*